Caxton Associates LP Veru Inc. Transaction History

Caxton Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.35 - $15.85 $53,170 - $193,734	12,223 New	12,223 $138,000
Q2 2021 Aug 16, 2021	SELL	$7.24 - $11.2 $242,112 - $374,539	-33,441 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.05 - $20.78 $269,200 - $694,903	33,441 New	33,441 $360,000
Q3 2020 Nov 16, 2020	SELL	$2.58 - $3.36 $267,489 - $348,358	-103,678 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.58 - $4.58 $267,489 - $474,845	103,678 New	103,678 $339,000

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.